Abstract
The pituitary is a unique organ that is key to maintaining end organ function. However, it is particularly susceptible to some tumors, cysts, and infiltrates. Disruption of pituitary function may help target symptom etiology, but can lead to significant morbidity and mortality if not treated effectively.
Patients can present with similar symptom of mass effect, headaches, and pituitary deficiencies despite disparate types of lesions. In some cases, the patient is asymptomatic, and the lesion is found incidentally on Computerized Tomography (CT)/Magnetic resonance imaging (MRI) imaging. Treatment may depend on the type of lesion found on MRI or after surgical pathology when a definitive diagnosis is acquired.
Disorders such as empty sella syndrome may be primary or secondary to other disorders such as intracranial hypertension or occur after tumor resection. Infiltrative and infective disorders may be primary or localized to the pituitary, or may result secondarily from other system diseases. Cysts or tumors beginning in embryonic development can become symptomatic, with growth impacting the optic apparatus resulting in mass effect symptoms such as headaches and/or visual changes. Other tumors may originate in the hypothalamus, grow downward and impact the optic apparatus and the pituitary gland.
Assessment includes a detailed history and physical, MRI and biochemical and dynamic testing for pituitary dysfunction. MRI may have characteristics suggestive of a diagnosis but surgical pathology is often required for a definitive diagnosis. Treatment is often dictated by tumor or lesion histology.
Nursing assessment includes patient emotional, social and executive functions, resources, family history including parental and personal exposures. Together these form the basis of patient education, preparation for further testing and treatment planning decisions. The patient’s family can be important historians of patient symptoms particularly in the event of cognitive and memory dysfunction.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- ACTH:
-
Adrenocorticotrophic hormone
- AIP:
-
Aryl hydrocarbon–interacting protein gene
- CP:
-
Craniopharyngioma
- CSF:
-
Cerebrospinal fluid
- CT:
-
Computerized tomography
- DI:
-
Diabetes insipidus
- ES:
-
Empty sella
- FSH:
-
Follicle stimulating hormone
- GSU:
-
Glycoprotein hormone subunits
- HPA:
-
Hypothalamic-pituitary-adrenal (axis)
- ICP:
-
Intracranial pressure
- IIH:
-
Idiopathic intracranial hypertension
- LAR:
-
Long acting release
- LCH:
-
Langerhans Cell Histiocytosis
- LDL:
-
Low density lipoprotein
- LH:
-
Luteinizing hormone
- LHH:
-
Lymphocytic hypophysitis
- LINH:
-
Lymphocytic infundibuloneurohy pophysitis
- MEN-1:
-
Multiple endocrine neoplasia-type 1
- MRI:
-
Magnetic resonance imaging
- PC:
-
Pituitary carcinoma
- PES:
-
Primary empty sella
- PH:
-
Pituitary hypophysitis
- QoL:
-
Quality of life
- RCC:
-
Rathke’s cleft cysts
- SES:
-
Secondary empty sella
- SSA:
-
Somatostatin analogues (ligands)
- SSTR:
-
Somatostatin receptor
- TSH:
-
Thyroid stimulating hormone
- WHO:
-
World Health Organization
References
Algahtani AY, Algahtani HA, Jamjoom AB, Samkari AM, Marzuk YI. De novo craniopharyngioma of the fourth ventricle: case report and review of literature. Asian J Neurosurg. 2018;13(1):62–5. https://doi.org/10.4103/1793-5482.185063.
Auer MK, Stieg MR, Crispin A, Sievers C, Stalla GK, Kopczak A. Primary empty Sella syndrome and the prevalence of hormonal dysregulation—a systematic review. Dtsch Arztebl Int. 2018;115:99–105. https://doi.org/10.3238/arztebl.2018.0099.
Bal E, Öge K, Berker M. Endoscopic endonasal transsphenoidal surgery, a reliable method for treating primary and recurrent/residual craniopharyngiomas: nine years of experience. World Neurosurg. 2016;94:375–85.
Ball AK, Clarke CE. Idiopathic intracranial hypertension. Lancet Neurol. 2006;5:433–42.
Ball AK, Howman A, Wheatley K, Burdon MA, Matthews T, Jacks AS, Lawden M, Sivaguru A, Furmston A, Howell S, Sharrack S, Davies MB, Sinclair AJ, Clarke CE. A randomised controlled trial of treatment for idiopathic intracranial hypertension. J Neurol. 2011;258:874–81. https://doi.org/10.1007/s00415-010-5861-4.
Bernreuther C, Illies C, Flitsch J, Buchfelder M, Buslei R, Glatzel M, Saeger W. IgG4-related hypophysitis is highly prevalent among cases of histologically confirmed hypophysitis. Brain Pathol. 2017;27(6):839–45. https://doi.org/10.1111/bpa.12459. Epub 2017 Jan 11.
Bi WL, Larsen AG, Dunn IF. Genomic alterations in sporadic pituitary tumors. Curr Neurol Neurosci Rep. 2018;18:4. https://doi.org/10.1007/s11910-018-0811-0.
Carmichael JD. Anterior pituitary failure. In: Melmed S, editor. Pituitary. 4th ed. London: Elsevier; 2017. p. 329–63.
Carroll KT, Lochte BC, Chen JY, Snyder VS, Carter BS, Chen CC. Intraoperative magnetic resonance imaging-guided biopsy in the diagnosis of suprasellar langerhans cell histiocytosis. World Neurosurg. 2018;112:6–13. https://doi.org/10.1016/j.wneu.2017.12.184. Epub 2018 Jan 6.
Catford S, Wang YY, Wong R. Pituitary stalk lesions: systematic review and clinical guidance. Clin Endocrinol. 2016;85:507–21.
Chatziralli I, Theodossiadis P, Theodossiadis G, Asproudis I. Perspectives on diagnosis and management of adult idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol. 2018;256(7):1217–24. https://doi.org/10.1007/s00417-018-3970-4. Accessed 26 Mar 2018.
Chiloiro S, Giampietro A, Bianchi A, Tartaglione T, Capobianco A, Anile C, De Marinis L. Diagnosis of endocrine disease: primary empty Sella: a comprehensive review. Eur J Endocrinol. 2017;177(6):R275–85.
Crock PA. Cytosolic autoantigens in lymphocytic hypophysitis. J Clin Endocrinol Metab. 1998;83:609–18.
Daniels AB, Liu GT, Volpe NJ, et al. Profiles of obesity, weight gain and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Opthalmol. 2007;143:635–41.
Digre KB, Bruce BB, McDermott MP, Galetta KM, Balcer LJ, Wall M. Quality of life in idiopathic intracranial hypertension at diagnosis: IIH treatment trial results. Neurology. 2015;84(24):2449–56. https://doi.org/10.1212/WNL.0000000000001687.
Dillard T, Yedinak CG, Alumkal J, Fleseriu M. Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes. Pituitary. 2010;13:29–38.
Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system Tumors diagnosed in the United States in 2005–2009. Neuro-Oncology. 2012;14(Suppl 5):v1–v49. https://doi.org/10.1093/neuonc/nos218.
Dubey A, Patwardhan RV, Sampth S, Santosh V, Kolluri S, Nanda A. Intracranial fungal granuloma: analysis of 40 patients and review of the literature. Surg Neurol. 2005;63:254–60.
Elgamal ME, Mohamed RMH, Fiad T, Elgamal EA. Granulomatous hypophysitis: rare disease with challenging diagnosis. Clin Case Rep. 2017;5(7):1147–51. https://doi.org/10.1002/ccr3.1007.
Fahlbusch R, Buchfelder M. Pituitary surgery. In: Melmed S, editor. The pituitary. 4th ed. London: Elsevier; 2017. p. 671–87.
Faje A. Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights. Pituitary. 2016;19:82–92. https://doi.org/10.1007/s11102-015-0671-4.
Fleseriu M. Pituitary dysfunction in systemic disorders. In: Melmed S, editor. The pituitary. 4th ed. London: Elsevier; 2017. p. 365–38.
Fleseriu M, Yedinak C, Campbell C, Delashaw JB. Significant headache improvement after transsphenoidal surgery in patients with small sellar lesions. J Neurosurg. 2009;110(2):354–8. https://doi.org/10.3171/2008.8.JNS08805.
Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159–65. https://doi.org/10.1212/WNL.0b013e3182a55f1.
Gellner V, Kurschel S, Scarpatetti M, Mokry M. Lymphocytic hypophysitis in the pediatric population. Childs Nerv Syst. 2008;24(7):785–92. https://doi.org/10.1007/s00381-007-0577-1. Epub 2008 Feb 26.
Glezer A, Bronstein MD. Pituitary autoimmune disease: nuances in clinical presentation. Endocrine. 2012;42:74–9. https://doi.org/10.1007/s12020-012-9654-7.
González-Andrades M, García-Serrano JL, Gallardo MCG, Mcalinden C. Multiple cranial nerve involvement with idiopathic intracranial hypertension. QJM. 2016;109(4):265–6. https://doi.org/10.1093/qjmed/hcv217.
Guedes BF, Souza MNP, Barbosa BJAP, et al. Intracranial germinoma causing cerebral haemiatrophy and hypopituitarism. Pract Neurol. 2018;18(4):306–10. https://doi.org/10.1136/practneurol-2017-001771.
Gustina A, Frara S, Spina A, Mortini P. The hypothalamus. In: Melmed S, editor. The pituitary. 4th ed. London: Elsevier; 2017. p. 291–327.
Gutenberg A, Caturegli P, Metz I, et al. Necrotizing infundibulo-hypophysitis: an entity too rare to be true? Pituitary. 2012;15(2):202–8. https://doi.org/10.1007/s11102-011-0307-2.
Huo CW, Caputo C, Wang YY. Suprasellar keratinous cyst: a case report and review on its radiological features and treatment outcome. Surg Neurol Int. 2018;9:15. https://doi.org/10.4103/sni.sni_269_17.
Idiopathic Intracranial Hypertension. National Eye Institute. Last reviewed April 2014. https://nei.nih.gov/health/iih/intracranial.
Iplikcioglu AC, Bek S, Bikmaz K, Ceylan D, Gokduman CA. Aspergillus pituitary abscess. Acta Neurochir. 2004;146:521–4. https://doi.org/10.1007/s00701-004-0256-x.
Iwama S, De Remigis A, Callahan MK, Slovin SF, Wolchok JD, Caturegli P. Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody. Sci Transl Med. 2014;6:230ra45.
Kleinschmidt JJ, Digre KB, Hanover R. Idiopathic intracranial hypertension: relationship to depression, anxiety and quality of life. Neurology. 2000;54:319–24.
Larkin S, Karavitaki N, Ansorg O. Chapter 17: Rathke’s cleft cyst. In: Fliers E, Korbonits M, Romijn JA, editors. Handbook of clinical neurology (3rd series), vol. 124. Amsterdam: Elsevier B.V; 2014.
Laws ER, Vance ML, Jane JA Jr. Hypophysitis. Pituitary. 2006;9:331–3.
Li J, Jia HW, Wang CL, Zhang R, Qu MY, Li W, Yuan MH, Cui J, He Q, Wei HY, Zhu TH, Ma ZS, Liu W, Dong ZL, Gao ZG. Primary empty Sella of 123 cases of clinical analysis. Chin J Intern Med. 2017;56(4):268–72. https://doi.org/10.3760/cma.j.issn.0578-1426.2017.04.006.
Maya MM, Pressman BK. Piutitary imaging. In: Melmed S, editor. The pituitary. 4th ed. London: Elsevier; 2017. p. 645–70.
McDermott MT. Infiltrative diseases of the pituitary gland. In: Wierman ME, editor. Diseases of the pituitary. Contemporary endocrinology, vol. 3. New York: Humana Press; 1997. p. 395–6.
Melmed S, Kleinberg D. Chapter 9—pituitary masses and tumors. In: Melmed S, Kenneth S, Polonsky P, Larsen R, Kronenberg HM, editors. Williams textbook of endocrinology. 13th ed. Philadelphia, PA: Elsevier; 2016. p. 232–99.
Mittal R, Kalra P, Dharmalingam M, Verma RG, Kulkarni S, Shetty P. Lymphocytic hypophysitis masquerading as pituitary adenoma. 1. Lymphocytic hypophysitis masquerading as pituitary adenoma. Indian J Endocrinol Metab. 2012;16(8):304–6.
Moshkin O, Albrecht S, Bilboa JM, Kovacs K. Nonpituitary tumors of the sellar region. In: Melmed S, editor. The pituitary. 3rd ed. London: Elsevier; 2011. p. 119–66. https://doi.org/10.1016/B978-0-12-380926-1.10015-X.
Müller HL. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes. 2016;23(1):81–9. https://doi.org/10.1097/MED.0000000000000214.
Néel A, Artifoni M, Donadieu J, Lorillon G, Hamidou M, Tazi A. Langerhans cell histiocytosis in adults. Rev Med Interne. 2015;36(10):658–67.
Patel VS, Thamboo A, Quon J, Nayak JV, Hwang PH, Edwards M, Patel ZM. Outcomes after endoscopic endonasal resection of craniopharyngiomas in the pediatric population. World Neurosurg. 2017;108:6–14. https://doi.org/10.1016/j.wneu.2017.08.058.
PDQ® Pediatric Treatment Editorial Board. PDQ Langerhans Cell Histiocytosis Treatment. Bethesda, MD: National Cancer Institute. 2018. https://www.cancer.gov/types/langerhans/patient/langerhans-treatment-pdq. Accessed 28 Apr 2018.
Per H, Canpolat M, Gümüş H, Poyrazoğlu HG, Yıkılmaz A, Karaküçük S, Doğan H, Kumandaş S. Clinical spectrum of the pseudotumor cerebri in children: etiological, clinical features, treatment and prognosis. Brain and Development. 2013;35(6):561–8. https://doi.org/10.1016/j.braindev.2012.08.008. Epub 2012 Sep 13.
Perry BG, Cotter JD, Mejuto G, Mündel T, Lucas SJE. Cerebral hemodynamics during graded Valsalva maneuvers. Front Physiol. 2014;5:349. https://doi.org/10.3389/fphys.2014.00349.
Prieto R, Pascual JM, Rosdolsky M, Barrios L. Preoperative assessment of craniopharyngioma adherence: magnetic resonance imaging findings correlated with the severity of tumor attachment to the hypothalamus. World Neurosurg. 2018;110:e404–26. https://doi.org/10.1016/j.wneu.2017.11.012. Epub 2017 Nov 11.
Rangwala LM, Liu GT. Pediatric idiopathic intracranial hypertension. Surv Ophthalmol. 2007;52(6):597–617.
Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V, Trouillas J, Dekkers OM. The European Society of Endocrinology European Society of endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol. 2018;178:G1–G24. https://doi.org/10.1530/EJE-17-0796.
Sajko T, Gnjidić Ž, Sesar N, Malenica M. Sphenoid sinus aspergilloma in trans-sphenoidal surgery for pituitary adenomas. Acta Neurochir. 2015;157(8):1345–51 discussion 1351. https://doi.org/10.1007/s00701-015-2485-6.
Schlosser RJ, Bolger WE. Spontaneous nasal cerebrospinal fluid leaks and empty Sella syndrome: a clinical association. Am J Rhinol. 2003;17(2):91–6.
Sheldon CA, Paley GL, Xiao R, Kesler A, Eyal O, Ko MW, Boisvert CJ, Avery RA, Salpietro V, Phillips PH, Heidary G, McCormack SE, Liu GT. Pediatric idiopathic intracranial hypertension: age, gender, and anthropometric features at diagnosis in a large, retrospective multisite cohort. Ophthalmology. 2016;123(11):2424–31. https://doi.org/10.1016/j.ophtha.2016.08.004. Epub 2016 Sep 28.
Shi J, Zhang J, Wu Q, Chen G, Zhang H, Bo W. Granulomatous hypophysitis: two case reports and literature review. J Zhejiang Univ Sci B. 2009;10(7):552–8. https://doi.org/10.1631/jzus.B0820355.
Shin JL, Asa SL, Woodhouse LJ, Smyth HS, Ezzat S. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke’s cleft cyst, and arachnoid cyst. J Clin Endocrinol Metab. 1999;84(11):3972–82.
Shivapathasundram G, Wickremesekera AC, Tan ST, et al. Tumour stem cells in meningioma: a review. J Clin Neurosci. 2018;47:66–71.
Tillotson CV, Bhimji SS. Histiocytosis, Langerhans cell. In: StatPearls [internet]. Treasure Island, FL: StatPearls; 2018. https://www-ncbi-nlm-nih-gov.liboff.ohsu.edu/books/NBK430885.
Tyrrell JB, Finding W, Aron DC. Hypothalamus and pituitary: chapter 2. In: Greenspan FS, Baxter JD, editors. Basic & clinical endorinology. 4th ed. Norwalk, CT: Appelton & Lange; 1994. p. 91.
Wall M. Idiopathic intracranial hypertension. Neurol Clin. 2010;28(3):593–617. https://doi.org/10.1016/j.ncl.2010.03.003.
Yoo F, Kuan EC, Heaney AP, et al. Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review. Pituitary. 2018;21:290. https://doi.org/10.1007/s11102-018-0872-8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Yedinak, C. (2019). Sella and Suprasellar Brain Tumours and Infiltrarive Disorders Affecting the HPA-Axis. In: Llahana, S., Follin, C., Yedinak, C., Grossman, A. (eds) Advanced Practice in Endocrinology Nursing. Springer, Cham. https://doi.org/10.1007/978-3-319-99817-6_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-99817-6_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99815-2
Online ISBN: 978-3-319-99817-6
eBook Packages: MedicineMedicine (R0)